Got osteoarthritis? Get moving

(HealthDay)—Is arthritis pain getting in the way of your fitness plans? That need not be the case.In fact,physical activitycan be vital to your continued mobility.Osteoarthritis is a

Updated on: April 07,2024

Got osteoarthritis? Get moving

(HealthDay)—Is arthritis pain getting in the way of your fitness plans? That need not be the case.In fact,physical activitycan be vital to your continued mobility.Osteoarthritis is a

Updated on:April 07,2024

How dangerous is the mpox clade Ib public health emergency? | News Desk

Updated on: August 29,2024

How dangerous is the mpox clade Ib public health emergency? | News Desk

Updated on:August 29,2024

How HIV research has reshaped modern medicine

If it wasn’t for the decades of HIV research, we would not have had the COVID-19 vaccines so rapidly.

Updated on: November 28,2024

How HIV research has reshaped modern medicine

If it wasn’t for the decades of HIV research, we would not have had the COVID-19 vaccines so rapidly.

Updated on:November 28,2024

Exercise is medicine for cancer and every dose counts, even in late stages of the disease: Study

by Edith Cowan UniversityA single bout of exercise has been found to produce anti-cancer proteins called myokines which can significantly inhibit tumour growth even in advanced stages of the dise

Updated on: February 18,2024

Exercise is medicine for cancer and every dose counts, even in late stages of the disease: Study

by Edith Cowan UniversityA single bout of exercise has been found to produce anti-cancer proteins called myokines which can significantly inhibit tumour growth even in advanced stages of the dise

Updated on:February 18,2024

Medication used to control blood sugar in people with type 2 diabetes may also reduce risk of autoimmune diseases

by American College of RheumatologyDipeptidyl peptidase-4 inhibitors commonly used to control blood sugar levels in people with type 2 diabetes may also reduce the risk of autoimmune diseases in these

Updated on: April 07,2024

Medication used to control blood sugar in people with type 2 diabetes may also reduce risk of autoimmune diseases

by American College of RheumatologyDipeptidyl peptidase-4 inhibitors commonly used to control blood sugar levels in people with type 2 diabetes may also reduce the risk of autoimmune diseases in these

Updated on:April 07,2024

Study examines the course of back pain over time

by WileyCredit: CC0 Public DomainBack pain is among the most frequently reported health problems in the world. New research published inArthritis Care & Research, an official journal of

Updated on: June 01,2024

Study examines the course of back pain over time

by WileyCredit: CC0 Public DomainBack pain is among the most frequently reported health problems in the world. New research published inArthritis Care & Research, an official journal of

Updated on:June 01,2024

The double face of RNase as a treatment for systemic autoimmune diseases

by Osaka UniversityThe RNA-degrading enzyme enhances the function of immune complexes formed by autoantibodies against Ro/SSA and La/SSB antigens. Credit: Ryota Naito et al. JCI Insight 2023Syste

Updated on: April 22,2024

The double face of RNase as a treatment for systemic autoimmune diseases

by Osaka UniversityThe RNA-degrading enzyme enhances the function of immune complexes formed by autoantibodies against Ro/SSA and La/SSB antigens. Credit: Ryota Naito et al. JCI Insight 2023Syste

Updated on:April 22,2024

New insights reveal how house dust mites trigger allergic asthma by activating immune system

byUniversity of PittsburghMouse lymph node with hotspots of IL2 activity circled. Credit: Kun HeNew research from the University of Pittsburgh uncovers how inhaled house dust mites, a common tri

Updated on: November 24,2024

New insights reveal how house dust mites trigger allergic asthma by activating immune system

byUniversity of PittsburghMouse lymph node with hotspots of IL2 activity circled. Credit: Kun HeNew research from the University of Pittsburgh uncovers how inhaled house dust mites, a common tri

Updated on:November 24,2024

Disturbed gut virome with potent interferonogenic property in systemic lupus erythematosus

by Science China PressThe taxonomic profile and the interferon-α-stimulatory capacity of gut virus-like particles in patients with systemic lupus erythematosus. Credit: Science China PressSystemi

Updated on: May 09,2024

Disturbed gut virome with potent interferonogenic property in systemic lupus erythematosus

by Science China PressThe taxonomic profile and the interferon-α-stimulatory capacity of gut virus-like particles in patients with systemic lupus erythematosus. Credit: Science China PressSystemi

Updated on:May 09,2024

App tackles problem of 'glue ear' in children

by Alex Earnshaw,Aston UniversityAston University is tackling the problem of 'glue ear' in children with a free* hearing test app for any concerned families.The main cause of temporary c

Updated on: March 02,2024

App tackles problem of 'glue ear' in children

by Alex Earnshaw,Aston UniversityAston University is tackling the problem of 'glue ear' in children with a free* hearing test app for any concerned families.The main cause of temporary c

Updated on:March 02,2024

Study reveals way to predict side-effect risk from common immune suppressant medication

by University of NottinghamMethotrexate (MTX) is an anti-metabolite most commonly used in chemotherapy and immunosuppressant in auto-immune diseases. Credit: University of NottinghamA major new s

Updated on: January 29,2024

Study reveals way to predict side-effect risk from common immune suppressant medication

by University of NottinghamMethotrexate (MTX) is an anti-metabolite most commonly used in chemotherapy and immunosuppressant in auto-immune diseases. Credit: University of NottinghamA major new s

Updated on:January 29,2024

COVID-19 immunity may last six months or more

by Meghan Rosen,Howard Hughes Medical InstituteScientists found traces of SARS-CoV-2 (green) in cells lining people’s intestines three months after infection. Antibodies may evolve in response t

Updated on: April 10,2024

COVID-19 immunity may last six months or more

by Meghan Rosen,Howard Hughes Medical InstituteScientists found traces of SARS-CoV-2 (green) in cells lining people’s intestines three months after infection. Antibodies may evolve in response t

Updated on:April 10,2024